Norman Heyden

849 total citations
8 papers, 498 citations indexed

About

Norman Heyden is a scholar working on Orthopedics and Sports Medicine, Oncology and Nephrology. According to data from OpenAlex, Norman Heyden has authored 8 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Orthopedics and Sports Medicine, 4 papers in Oncology and 2 papers in Nephrology. Recurrent topics in Norman Heyden's work include Bone health and osteoporosis research (5 papers), Bone health and treatments (4 papers) and Statistical Methods in Clinical Trials (2 papers). Norman Heyden is often cited by papers focused on Bone health and osteoporosis research (5 papers), Bone health and treatments (4 papers) and Statistical Methods in Clinical Trials (2 papers). Norman Heyden collaborates with scholars based in United States, Israel and Norway. Norman Heyden's co-authors include Anastasia G. Daifotis, Susan L. Greenspan, Peter H. Gann, Keaven M. Anderson, K. S. Liu, A. Carides, Leanne M. Ward, Peter A. Smith, Robert D. Steiner and F. H. Glorieux and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, JNCI Journal of the National Cancer Institute and Osteoporosis International.

In The Last Decade

Norman Heyden

8 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Norman Heyden United States	7	177	164	141	126	103	8	498
J P Bilezikian United States	12	107 0.6×	257 1.6×	104 0.7×	181 1.4×	114 1.1×	19	697
Pietra Pennisi Italy	10	267 1.5×	150 0.9×	52 0.4×	203 1.6×	50 0.5×	13	594
N. Morabito Italy	17	307 1.7×	296 1.8×	84 0.6×	159 1.3×	53 0.5×	36	800
Pablo Román‐García Spain	14	120 0.7×	106 0.6×	142 1.0×	149 1.2×	77 0.7×	19	700
Ylva Pernow Sweden	17	212 1.2×	246 1.5×	178 1.3×	153 1.2×	29 0.3×	31	740
Paulo Gustavo Sampaio Lacativa Brazil	12	135 0.8×	74 0.5×	45 0.3×	119 0.9×	51 0.5×	23	437
Gino V. Segre United States	9	119 0.7×	210 1.3×	91 0.6×	126 1.0×	71 0.7×	13	687
Roberto Valenti Italy	9	384 2.2×	173 1.1×	88 0.6×	207 1.6×	19 0.2×	15	611
Quanle Qi United States	7	239 1.4×	257 1.6×	71 0.5×	87 0.7×	69 0.7×	7	574
V. M. Stathopoulos United States	9	114 0.6×	130 0.8×	296 2.1×	97 0.8×	82 0.8×	12	619

Countries citing papers authored by Norman Heyden

Since Specialization

Citations

This map shows the geographic impact of Norman Heyden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Heyden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Heyden more than expected).

Fields of papers citing papers by Norman Heyden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Heyden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Heyden. The network helps show where Norman Heyden may publish in the future.

Co-authorship network of co-authors of Norman Heyden

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Heyden. A scholar is included among the top collaborators of Norman Heyden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Heyden. Norman Heyden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Cosman, Felicia, Nigel Gilchrist, Michael R. McClung, et al.. (2015). A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates. Osteoporosis International. 27(1). 377–386. 19 indexed citations

Halse, Johan, Susan L. Greenspan, Felicia Cosman, et al.. (2014). A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study of the Calcium-Sensing Receptor Antagonist MK-5442 in the Treatment of Postmenopausal Women With Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 99(11). E2207–E2215. 35 indexed citations

Adunsky, Abraham, Julie Chandler, Norman Heyden, et al.. (2010). MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study. Archives of Gerontology and Geriatrics. 53(2). 183–189. 46 indexed citations

Ward, Leanne M., Frank Rauch, Michael P. Whyte, et al.. (2010). Alendronate for the Treatment of Pediatric Osteogenesis Imperfecta: A Randomized Placebo-Controlled Study. The Journal of Clinical Endocrinology & Metabolism. 96(2). 355–364. 151 indexed citations

Kaplan, Steven A., Claus G. Roehrborn, Alan G. Meehan, et al.. (2009). PCPT: Evidence That Finasteride Reduces Risk of Most Frequently Detected Intermediate- and High-grade (Gleason Score 6 and 7) Cancer. Urology. 73(5). 935–939. 37 indexed citations

Liu, K. S., Norman Heyden, A. Carides, et al.. (2007). Detection Bias Due to the Effect of Finasteride on Prostate Volume: A Modeling Approach for Analysis of the Prostate Cancer Prevention Trial. JNCI Journal of the National Cancer Institute. 99(18). 1366–1374. 80 indexed citations

Bone, Henry G., Susan L. Greenspan, Clark McKeever, et al.. (2000). Alendronate and Estrogen Effects in Postmenopausal Women with Low Bone Mineral Density¹. The Journal of Clinical Endocrinology & Metabolism. 85(2). 720–726. 125 indexed citations

Bell, Nicole F., Robert W. Downs, Clark McKeever, et al.. (1999). Differential Effects of Alendronate and Estrogen on the Rate of Bone Loss After Discontinuation of Treatment. Menopause The Journal of The North American Menopause Society. 6(4). 357–358. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact